Kim RB - Search Results

1

Prospective evaluation of a pharmacogenetics-guided warfarin loading and maintenance dose regimen for initiation of therapy.

Gong IY, Tirona RG, Schwarz UI, Crown N, Dresser GK, Larue S, Langlois N, Lazo-Langner A, Zou G, Roden DM, Stein CM, Rodger M, Carrier M, Forgie M, Wells PS, Kim RB. Gong IY, et al. Among authors: kim rb. Blood. 2011 Sep 15;118(11):3163-71. doi: 10.1182/blood-2011-03-345173. Epub 2011 Jul 1. Blood. 2011. PMID: 21725053 Free article. Clinical Trial.

2

The drug transporter P-glycoprotein limits oral absorption and brain entry of HIV-1 protease inhibitors.

Kim RB, Fromm MF, Wandel C, Leake B, Wood AJ, Roden DM, Wilkinson GR. Kim RB, et al. J Clin Invest. 1998 Jan 15;101(2):289-94. doi: 10.1172/JCI1269. J Clin Invest. 1998. PMID: 9435299 Free PMC article.

3

Modulation by dietary salt of verapamil disposition in humans.

Darbar D, Fromm MF, Dell'Orto S, Kim RB, Kroemer HK, Eichelbaum M, Roden DM. Darbar D, et al. Among authors: kim rb. Circulation. 1998 Dec 15;98(24):2702-8. doi: 10.1161/01.cir.98.24.2702. Circulation. 1998. PMID: 9851956 Clinical Trial.

4

Human MRP3 transporter: identification of the 5'-flanking region, genomic organization and alternative splice variants.

Fromm MF, Leake B, Roden DM, Wilkinson GR, Kim RB. Fromm MF, et al. Among authors: kim rb. Biochim Biophys Acta. 1999 Jan 8;1415(2):369-74. doi: 10.1016/s0005-2736(98)00233-8. Biochim Biophys Acta. 1999. PMID: 9889399 Free article.

5

Inhibition of P-glycoprotein-mediated drug transport: A unifying mechanism to explain the interaction between digoxin and quinidine [seecomments].

Fromm MF, Kim RB, Stein CM, Wilkinson GR, Roden DM. Fromm MF, et al. Among authors: kim rb. Circulation. 1999 Feb 2;99(4):552-7. doi: 10.1161/01.cir.99.4.552. Circulation. 1999. PMID: 9927403

6

Genetic polymorphism of (S)-mephenytoin 4'-hydroxylation in populations of African descent.

Xie HG, Kim RB, Stein CM, Wilkinson GR, Wood AJ. Xie HG, et al. Among authors: kim rb. Br J Clin Pharmacol. 1999 Sep;48(3):402-8. doi: 10.1046/j.1365-2125.1999.00009.x. Br J Clin Pharmacol. 1999. PMID: 10510153 Free PMC article.

7

Allelic, genotypic and phenotypic distributions of S-mephenytoin 4'-hydroxylase (CYP2C19) in healthy Caucasian populations of European descent throughout the world.

Xie HG, Stein CM, Kim RB, Wilkinson GR, Flockhart DA, Wood AJ. Xie HG, et al. Among authors: kim rb. Pharmacogenetics. 1999 Oct;9(5):539-49. Pharmacogenetics. 1999. PMID: 10591534

8

Molecular basis of ethnic differences in drug disposition and response.

Xie HG, Kim RB, Wood AJ, Stein CM. Xie HG, et al. Among authors: kim rb. Annu Rev Pharmacol Toxicol. 2001;41:815-50. doi: 10.1146/annurev.pharmtox.41.1.815. Annu Rev Pharmacol Toxicol. 2001. PMID: 11264478 Review.

9

Identification and functional characterization of a new CYP2C9 variant (CYP2C9*5) expressed among African Americans.

Dickmann LJ, Rettie AE, Kneller MB, Kim RB, Wood AJ, Stein CM, Wilkinson GR, Schwarz UI. Dickmann LJ, et al. Among authors: kim rb. Mol Pharmacol. 2001 Aug;60(2):382-7. doi: 10.1124/mol.60.2.382. Mol Pharmacol. 2001. PMID: 11455026

10

Polymorphisms in OATP-C: identification of multiple allelic variants associated with altered transport activity among European- and African-Americans.

Tirona RG, Leake BF, Merino G, Kim RB. Tirona RG, et al. Among authors: kim rb. J Biol Chem. 2001 Sep 21;276(38):35669-75. doi: 10.1074/jbc.M103792200. Epub 2001 Jul 26. J Biol Chem. 2001. PMID: 11477075 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

414 results

Search Page

Filters